Efficacy and safety of direct-acting antiviral agents for HCV in mild-to-moderate chronic kidney disease. [electronic resource]
Producer: 20210310Description: 46-52 p. digitalISSN:- 2013-2514
- 2-Naphthylamine
- Amides -- therapeutic use
- Anilides -- therapeutic use
- Antiviral Agents -- adverse effects
- Benzimidazoles -- therapeutic use
- Benzofurans -- therapeutic use
- Carbamates -- therapeutic use
- Cyclopropanes -- therapeutic use
- Drug Combinations
- Drug Therapy, Combination
- Female
- Genotype
- Hepacivirus -- genetics
- Hepatitis C -- complications
- Humans
- Imidazoles -- therapeutic use
- Lactams, Macrocyclic -- therapeutic use
- Male
- Middle Aged
- Proline -- analogs & derivatives
- Pyrrolidines -- therapeutic use
- Quinoxalines -- therapeutic use
- Renal Insufficiency, Chronic -- complications
- Ritonavir -- therapeutic use
- Simeprevir -- therapeutic use
- Sofosbuvir -- therapeutic use
- Sulfonamides -- therapeutic use
- Sustained Virologic Response
- Uracil -- analogs & derivatives
- Valine -- analogs & derivatives
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Observational Study
There are no comments on this title.
Log in to your account to post a comment.